Mitochondria-specific targeting of noncanonical <i>EGR1</i> ntmRNA-coordinated mitophagy receptor BNIP3 homodimerization disrupts mitochondrial metabolism and suppresses hepatocellular carcinoma growth <i>in vitro</i> and <i>in vivo</i>
Yan Li(Beijing Tongren Hospital), Ji‐Fan Hu(Capital Medical University), Andrew R. Hoffman(Stanford University), Yijing Zhao(Jilin University), Jiuwei Cui(Jilin University), Wen Xue(Tianjin University of Science and Technology), Ying Meng(Sir Run Run Shaw Hospital), Lei Zhou(Virginia–Maryland College of Veterinary Medicine), Zilin Yan(Kunming Medical University), Wei Li(Yangtze University), Shanshan Liu(Fujian Medical University), Hui Li(Jilin University), Changhao Fu(Jilin University), Mengmeng Liu(Zhengzhou University), Shan Zong(Jianghan University)
Cited by 2
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
|Biomarker Research|2020|473